Neo-Farmaceutica

Neo-Farmacêutica is a Portuguese pharmaceutical company dedicated to the commercialization, marketing, and distribution of medicines, medical devices, and food supplements. Founded in 1968 and based in Lisbon, the company has established a strong presence in the Iberian market, particularly within therapeutic areas such as the central nervous system, gastroenterology, and respiratory health. In 2022, Neo-Farmacêutica was acquired by Norgine, a leading European specialist pharmaceutical company, integrating its operations into Norgine's broader European infrastructure. The company serves as a vital partner for international laboratories, providing local expertise in regulatory affairs and commercial strategy to ensure patient access to essential treatments in Portugal. Its portfolio includes well-known brands in the fields of mental health and digestive wellness.